GlobeNewswire Inc | Sep 30, 2021 04:05PM EDT

September 30, 2021

MOUNTAIN VIEW, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in the upcoming Lytham Partners Fall 2021 Investor Conference.

David Bruce, Iridexs President and Chief Executive Officer, is scheduled to present on Thursday, October 7, 2021, at 11:45 am ET. Interested parties may access a live and archived webcast of the presentation at www.iridex.com.

AboutIridexIridex Corporationis a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Companys proprietary MicroPulsetechnology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridexs current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases.Iridexproducts are sold inthe United Statesthrough a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit theIridexwebsite at www.iridex.com.

Investor Relations ContactLeigh Salvo(415) 937-5404investors@iridex.com